We are live on ! Find out more
KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
FCMI
1
Foresite Capital Management IV
California
$59M
RCM
2
RA Capital Management
Massachusetts
$26M
O
3
OrbiMed
New York
$24.7M
BlackRock
4
BlackRock
New York
$14.2M +$481K +59,002 +3%
NI
5
Nextech Invest
Switzerland
$14.2M -$2.71M -332,408 -12%
VVA
6
Vida Ventures Advisors
Massachusetts
$13.5M
Fidelity Investments
7
Fidelity Investments
Massachusetts
$12.7M -$2.78M -341,825 -14%
LCM
8
Lynx1 Capital Management
Puerto Rico
$12.2M +$2.64M +323,740 +19%
Viking Global Investors
9
Viking Global Investors
Connecticut
$11.1M
APM
10
Avidity Partners Management
Texas
$7.4M +$725 +89 +0%
Citadel Advisors
11
Citadel Advisors
Florida
$6.73M +$57.6K +7,073 +0.6%
Vanguard Group
12
Vanguard Group
Pennsylvania
$6.21M +$53.7K +6,593 +0.7%
FCMV
13
Foresite Capital Management V
California
$5.34M
NHAS
14
Novo Holdings A/S
Denmark
$4.98M
RSCM
15
Rock Springs Capital Management
Maryland
$4.56M
BC
16
Boxer Capital
California
$3.11M -$8.25M -1,012,559 -67%
HMC
17
Harvard Management Company
Massachusetts
$3.04M
State Street
18
State Street
Massachusetts
$2.83M -$27.2K -3,339 -0.7%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$2.63M +$88.8K +10,905 +3%
American Century Companies
20
American Century Companies
Missouri
$1.96M +$1.6K +196 +0.1%
Northern Trust
21
Northern Trust
Illinois
$1.31M -$47.3K -5,808 -3%
WP
22
Woodline Partners
California
$1.14M -$2.75M -337,271 -64%
Charles Schwab
23
Charles Schwab
California
$909K +$18.4K +2,257 +2%
CS
24
Candriam SCA
Luxembourg
$825K +$561K +68,941 +104%
Deutsche Bank
25
Deutsche Bank
Germany
$799K +$1.6K +196 +0.1%